All Products

Featured Products

Newest Products

Research Areas

10058-F4
featured

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 406757

CAS#: 403811-55-2

Description: 10058-F4 is a potent and selective c-Myc inhibitor, which markedly increases valproic acid-induced cell death in Jurkat and CCRF-CEM T-lymphoblastic leukemia cells. 10058-F4 inhibits proliferation, downregulates human telomerase reverse transcriptase and enhances chemosensitivity in human hepatocellular carcinoma cells. 10058-F4 induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia.


Price and Availability

Size
Price
50mg
USD 150
500mg
USD 900
5g
USD 3550
Size
Price
100mg
USD 250
1g
USD 1350
Size
Price
200mg
USD 450
2g
USD 2050

10058-F4, purity > 98%, is in stock. The same day shipping out after order is received. Note: the estimated shipping out time for order >8g may be 2 weeks.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 406757
Name: 10058-F4
CAS#: 403811-55-2
Chemical Formula: C12H11NOS2
Exact Mass: 249.0282
Molecular Weight: 249.346
Elemental Analysis: C, 57.80; H, 4.45; N, 5.62; O, 6.42; S, 25.72


Synonym: 10058-F4; 10058F4; 10058 F4.

IUPAC/Chemical Name: 5-[(4-ethylphenyl)methylene]-2-thioxo-4-thiazolidinone

InChi Key: SVXDHPADAXBMFB-JXMROGBWSA-N

InChi Code: InChI=1S/C12H11NOS2/c1-2-8-3-5-9(6-4-8)7-10-11(14)13-12(15)16-10/h3-7H,2H2,1H3,(H,13,14,15)/b10-7+

SMILES Code: O=C1NC(S/C1=C/C2=CC=C(CC)C=C2)=S


Technical Data

Appearance:
Yellow solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Certificate of Analysis:
View CoA: current batch, Lot#T7K09C18

QC Data:
View QC data: current batch, Lot#T7K09C18

Safety Data Sheet (MSDS):
View Material Safety Data Sheet (MSDS)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO, not in water

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

Harmonized System Code:
293490


References

1: Zhang M, Fan HY, Li SC. Inhibition of c-Myc by 10058-F4 induces growth arrest
and chemosensitivity in pancreatic ductal adenocarcinoma. Biomed Pharmacother.
2015 Jul;73:123-8. doi: 10.1016/j.biopha.2015.05.019. Epub 2015 Jun 1. PubMed
PMID: 26211592.

2: Mu Q, Ma Q, Lu S, Zhang T, Yu M, Huang X, Chen J, Jin J. 10058-F4, a c-Myc
inhibitor, markedly increases valproic acid-induced cell death in Jurkat and
CCRF-CEM T-lymphoblastic leukemia cells. Oncol Lett. 2014 Sep;8(3):1355-1359.
Epub 2014 Jun 24. PubMed PMID: 25120723; PubMed Central PMCID: PMC4114592.

3: Guo J, Parise RA, Joseph E, Egorin MJ, Lazo JS, Prochownik EV, Eiseman JL.
Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max
disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in
mice. Cancer Chemother Pharmacol. 2009 Mar;63(4):615-25. doi:
10.1007/s00280-008-0774-y. Epub 2008 May 29. PubMed PMID: 18509642; PubMed
Central PMCID: PMC2752825.

4: Lin CP, Liu JD, Chow JM, Liu CR, Liu HE. Small-molecule c-Myc inhibitor,
10058-F4, inhibits proliferation, downregulates human telomerase reverse
transcriptase and enhances chemosensitivity in human hepatocellular carcinoma
cells. Anticancer Drugs. 2007 Feb;18(2):161-70. PubMed PMID: 17159602.

5: Huang MJ, Cheng YC, Liu CR, Lin S, Liu HE. A small-molecule c-Myc inhibitor,
10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of
human acute myeloid leukemia. Exp Hematol. 2006 Nov;34(11):1480-9. PubMed PMID:
17046567.